Share This

Related Topics News -

     
 Title only   |   Print    Next page > 
     
《大行》交銀國際:醫藥板塊擁多重利好 趨勢穩中向好

2025-06-05T  
《大行》招商證券首予藥明合聯「強烈推薦」評級 看好未來增長潛力

2025-05-23T  
美國藥典委員會警告潛在關稅或打擊仿製藥公司

2025-04-24T  
《大行》中金列出內地主動偏股型基金首季重倉港股情況(表)

2025-04-23T  
關稅衝擊印度藥企 恐推升美國醫療成本

2025-04-16T  
《大行》大摩:訂單積壓趨勢及業績指引確認藥明系公司前景改善 上調目標價

2025-04-07T  
美國家衛生研究院禁止中國訪問基因及疾病數據庫 醫藥股顯著下滑

2025-04-07T  
藥明康德減持藥明合聯5,080萬股 套現近22億元

2025-04-02T  
《大行》建銀國際升藥明合聯目標價至52元 基本面及展望更明朗

2025-03-31T  
《大行》中金升藥明合聯目標價至45元 訂單維持強勁增長

2025-03-27T  
  Next page > 

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2025 Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.